Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non‐Hispanic whites in Texas: A case–control study
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
In a hospital‐based case–control study of 805 non‐Hispanic whites with cutaneous melanoma and 841 cancer‐free age‐, sex‐ and ethnicity‐matched control subjects, 3 VDR polymorphisms (i.e., Taq I, Bsm I and Fok I) were genotyped using blood samples collected between 1994 and 2006. We tested the hypothesis that the haplotypes and combined genotypes of these polymorphisms were associated with melanoma risk by interacting with known risk factors. Haplotypes t‐B‐F (adjusted odds ratio [OR], 0.52; 95% confidence interval [CI], 0.34–0.80) and t‐B‐f (adjusted OR, 0.51; CI, 0.27–0.94) were associated with a reduced risk when compared to T‐b‐f. The combined genotypes Tt+tt/Bb+BB/Ff+ff (adjusted OR, 0.69; CI, 0.52, 0.90) and Tt+tt/Bb+BB/FF (adjusted OR, 0.58; CI, 0.43, 0.78) were also associated with reduced risk, whereas the combined genotype TT/Bb+BB/Ff+ff genotype (adjusted OR, 2.35; CI, 1.13, 4.98) was associated with increased risk when compared to TT/bb/Ff+ff genotypes. On multivariate analysis, only the Taq I polymorphism was an independent risk factor, while the Fok I polymorphism interacted with skin color (p = 0.029), moles (p = 0.017) and first‐degree relatives with any cancer (p = 0.013) in modifying risk. Together, these findings suggest that VDR polymorphisms may directly affect or modify the risk associated with known melanoma risk factors. Larger, population‐based studies are needed to replicate our findings. © 2008 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The validity and practicality of sun-reactive skin types I through VI
Fitzpatrick, T. B. (1988) · Archives of Dermatology · doi:10.1001/archderm.1988.01670060015008 · Cited by 4,339
Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure
Gandini, S., Sera, F., Cattaruzza, M. S., Pasquini, P., Picconi, O., Boyle, P., & Melchi, C. F. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.016 · Cited by 1,266
Polymorphisms in the MTHFR and VDR genes and skin cancer risk
Han, J., Colditz, G. A., & Hunter, D. J. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl156 · Cited by 110
Cited by
Skin cancer and new treatment perspectives: A review
Simões, M. C. F., Sousa, J. J. S., & Pais, A. A. C. C. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.11.001 · Cited by 414
Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk
Raimondi, S., Johansson, H., Maisonneuve, P., & Gandini, S. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp103 · Cited by 265
Slominski, A. T., Brożyna, A. A., Zmijewski, M. A., Jóźwicki, W., Jetten, A. M., Mason, R. S., Tuckey, R. C., & Elmets, C. A. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.3 · Cited by 136
Olsen, C. M., Carroll, H. J., & Whiteman, D. C. (2010) · International Journal of Cancer · doi:10.1002/ijc.25243 · Cited by 89
Ogbah, Z., Visa, L., Badenas, C., Ríos, J., Puig-Butille, J. A., Bonifaci, N., Guino, E., Augé, J. M., Kolm, I., Carrera, C., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-26 · Cited by 28
“11, has more than 200 single-nucleotide polymorphisms (SNPs) [14] but only a few SNPs, considered to be functional [15], have been studied for their potential associations with melanoma susceptibility [16-21].”
Background
Metadata
- Authors
- Li, C., Liu, Z., Wang, L. E., Gershenwald, J. E., Lee, J. E., Prieto, V. G., Duvic, M., Grimm, E. A., & Wei, Q.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2008-02-25
- Volume
- 122
- Issue
- 9
- Pages
- 2077-2084
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2021564904
- Cited by
- 67
- References
- 3
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.